Literature DB >> 2782402

Plasma reciprocal pool specific activity predicts that of intracellular free leucine for protein synthesis.

F F Horber1, C M Horber-Feyder, S Krayer, W F Schwenk, M W Haymond.   

Abstract

We previously proposed that, during the infusion of either labeled leucine or its alpha-ketoacid, alpha-ketoisocaproate (KIC), the plasma specific activity (SA) of the transaminated product of the infused tracer ("reciprocal pool SA") may better reflect the intracellular leucine SA than the plasma SA of either infused tracer ("primary pool SA"). To test this hypothesis, 14 dogs were simultaneously infused intravenously with [3H]leucine and [14C]KIC, and blood and tissue compartments were sampled. The ratios of [3H]-leucine to [14C]leucine [( 3H]/[14C]leucine) in mixed tissue proteins and in the intracellular space of striated muscle were the same as the ratio of the isotope infusion rates and similar, although slightly lower (P less than 0.01), than [3H]KIC/[14C]leucine SA (ratio of reciprocal pool SA) in plasma. Plasma [3H]KIC/[14C]leucine SA were essentially identical to the [3H]/[14C] of leucine in 1) mixed liver proteins, 2) intrahepatic free leucine, and 3) fibrin. The [3H]/[14C]leucine in mixed renal proteins and in the intracellular space of kidney and erythrocytes were similar to those of the venous plasma [3H]/[14C]leucine SA. The plasma [3H]KIC and [14C]leucine SA (the reciprocal pool SA) were similar to the SA of [3H]- and [14C]leucine in the intracellular space of all organs investigated with the exception of kidney. Therefore, in postabsorptive dogs, the plasma SA of the transaminated product of the infused labeled KIC or leucine is an excellent predictor of the intracellular leucine SA in all tissues investigated with the exception of kidney.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2782402     DOI: 10.1152/ajpendo.1989.257.3.E385

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Phenylalanine kinetics in human adipose tissue.

Authors:  S W Coppack; M Persson; J M Miles
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Metabolic effects of liver transplantation in cirrhotic patients.

Authors:  L Luzi; G Perseghin; E Regalia; L P Sereni; A Battezzati; D Baratti; E Bianchi; I Terruzzi; H Hilden; L C Groop; A Pulvirenti; M R Taskinen; L Gennari; V Mazzaferro
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

3.  Mechanisms of postprandial protein accretion in human skeletal muscle. Insight from leucine and phenylalanine forearm kinetics.

Authors:  P Tessari; M Zanetti; R Barazzoni; M Vettore; F Michielan
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

4.  Human growth hormone prevents the protein catabolic side effects of prednisone in humans.

Authors:  F F Horber; M W Haymond
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

5.  Effects of insulin on ovine fetal leucine kinetics and protein metabolism.

Authors:  J R Milley
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  Mechanisms permitting nephrotic patients to achieve nitrogen equilibrium with a protein-restricted diet.

Authors:  B J Maroni; C Staffeld; V R Young; A Manatunga; K Tom
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

7.  Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.

Authors:  R Laager; R Ninnis; U Keller
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  Kidney, splanchnic, and leg protein turnover in humans. Insight from leucine and phenylalanine kinetics.

Authors:  P Tessari; G Garibotto; S Inchiostro; C Robaudo; S Saffioti; M Vettore; M Zanetti; R Russo; G Deferrari
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

9.  Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans.

Authors:  P De Feo; M G Gaisano; M W Haymond
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

10.  Reducing plasma HIV RNA improves muscle amino acid metabolism.

Authors:  Kevin E Yarasheski; Samuel R Smith; William G Powderly
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-09-14       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.